Dr. Jacob Ballon is our May 14 general meeting presenter. Dr. Ballon will discuss the current pipeline of medications for schizophrenia, focusing on the medications in clinical trials at the Department of Psychiatry at Stanford University. He will touch on the different mechanisms and how that may make for fewer, or at least different, side effect profiles but also why these medications may work well with existing ones.
Mental illness has never been a one-size-fits-all neurological disorder, and in women’s health the intersection between hormones and mood can further complicate life. But it doesn’t have to be that way said physician Karen Adams, director at Stanford University School of Medicine for Menopause and Healthy Aging. Understanding major depression, schizophrenia, and bipolar disorder during perimenopause and menopause can help women predisposed or diagnosed with a mental illness get through this transitional phase.